Central Plains Bancshares, Inc. Common Stock
NASDAQ:CPBIShell Companies
-$0.18 today
- Market cap
- $85.57M
- Beta
- 0.21
- P/E (TTM)
- 18.0
- EPS (TTM)
- $1.03
Volume 0.00M
Average 0.00M
CPBI Financing Cash Flow
Net cash exchanged with lenders and shareholders through borrowing, repayments, buybacks, and dividends.
Central Plains Bancshares, Inc. Common StockNASDAQ: CPBI
Financing Cash Flow · Q3 FY2025 · quarter ended Dec 2025
Financing cash flow growth accelerates
Q3 FY2025 financing cash flow of $23.62M rose 688.3% year over year, ahead of the +67.8% change in trailing-twelve-month financing cash flow. Sequentially, it rose 232.3% from the prior quarter. Over 3 fiscal years it compounded at +4.1% a year.
Context
- Financing cash flow amounted to 148.9% of revenue in FY2024, up 63.5 pp from a year earlier.
- Financing cash flow increased in 1 of the last 3 fiscal years.
- FY2024 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of +688.3% holds above the trailing-twelve-month pace of +67.8%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Financing Cash Flow history
USD · from the cash flow
- Latest · FY2024
- 40.67M USD
- Year-over-year change
- +100.0%
- 3-year CAGR
- +4.1%
| Period | Period end | Financing Cash Flow | YoY change |
|---|---|---|---|
| FY2024 | 2025-03-31 | 40.67M | +100.0% |
| FY2023 | 2024-03-31 | 20.34M | -21.9% |
| FY2022 | 2023-03-31 | 26.04M | -27.8% |
| FY2021 | 2022-03-31 | 36.04M | — |
Financing Cash Flow vs competitors
How CPBI compares with its peers on the latest reported figures
- CPBI's LTM Dec 2025 financing cash flow of $44.94M is the 3rd largest of the 8 companies compared; the peer median is $26.96M.
- Its year-over-year change of +67.8% is the 3rd highest of 6, against a peer median of +7.0%.
- Financing cash flow amounts to 151.4% of revenue for CPBI, versus a peer median of 42.2%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
ORIQUOrigin Investment Corp I Units | FY2025 | $71.54M | — | — | — |
| LTM Mar 2026 | $65.67M | — | — | — | |
| LTM Dec 2025 | $44.94M | +67.8% | +4.1% | 151.4% | |
AFJKAimei Health Technology Co., Ltd | LTM Mar 2026 | $32.3M | +7.0% | — | — |
| LTM Mar 2026 | $32.13M | +109.3% | — | 54.1% | |
| LTM Mar 2026 | $26.96M | -40.3% | +4.8% | 42.2% | |
| LTM Mar 2026 | $5.18M | -77.4% | — | — | |
| LTM Mar 2026 | $0 | +100.0% | — | 0.0% | |
| Peer median (excluding CPBI) | $26.96M | +7.0% | +4.8% | 42.2% | |
Competitors are the stored peer set for CPBI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Mar 2022 | FY2022 Mar 2023 | FY2023 Mar 2024 | FY2024 Mar 2025 |
|---|---|---|---|---|
| Net Income | 3.15M | 1.65M | 3.76M | 3.65M |
| Depreciation & Amortization | 497K | 503K | 518K | 455K |
| Deferred Income Tax | 237K | 78K | 46K | 255K |
| Stock-Based Compensation | 0 | 0 | 161K | 360K |
| Change in Working Capital | (391K) | (1.54M) | 376K | (1.14M) |
| Accounts Receivables | 0 | (382K) | (522K) | (852K) |
| Inventory | 0 | 0 | 0 | 0 |
| Accounts Payables | 0 | (1.45M) | 684K | (693K) |
| Other Working Capital | (391K) | 300K | 214K | 409K |
| Other Non-Cash Items | 785K | 3.78M | 848K | 871K |
| Operating Cash Flow | 4.28M | 4.47M | 5.71M | 4.46M |
| Capital Expenditures | (255K) | (303K) | (2.28M) | (7.53M) |
| Acquisitions (Net) | 0 | 0 | 0 | 0 |
| Purchases of Investments | (23.34M) | (63K) | (11.56M) | (6.2M) |
| Sales of Investments | 27.56M | 12.05M | 9.15M | 8.42M |
| Other Investing Activities | (52.46M) | (44.61M) | (26.46M) | (22.6M) |
| Investing Cash Flow | (48.49M) | (32.93M) | (31.16M) | (27.9M) |
| Debt Repayment | 645K | 0 | (3.31M) | 238K |
| Common Stock Issued | 0 | 0 | 39.36M | 0 |
| Common Stock Repurchased | 0 | 0 | 0 | (413K) |
| Dividends Paid | 0 | 0 | 0 | 0 |
| Other Financing Activities | 35.4M | 26.04M | (15.72M) | 40.85M |
| Financing Cash Flow | 36.04M | 26.04M | 20.34M | 40.67M |
| Effect of Forex Changes | 0 | 0 | 0 | 0 |
| Net Change in Cash | (8.17M) | (2.42M) | (5.11M) | 17.23M |
| Free Cash Flow | 4.02M | 4.17M | 3.43M | (3.07M) |
Central Plains Bancshares, Inc. Common Stock
NASDAQ:CPBI
Intrinsic Alpha fair value
Locked
Current Price
$20.51
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.